CARAMANTI, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 558
EU - Europa 288
AS - Asia 187
AF - Africa 29
SA - Sud America 25
Totale 1.087
Nazione #
US - Stati Uniti d'America 548
IT - Italia 63
SG - Singapore 58
CN - Cina 55
UA - Ucraina 40
SE - Svezia 37
DE - Germania 35
TR - Turchia 26
RU - Federazione Russa 25
CI - Costa d'Avorio 23
IE - Irlanda 23
BR - Brasile 22
FI - Finlandia 19
GB - Regno Unito 16
DK - Danimarca 15
HK - Hong Kong 15
KR - Corea 10
VN - Vietnam 10
IN - India 6
CA - Canada 5
JP - Giappone 4
MX - Messico 4
PL - Polonia 4
AR - Argentina 3
ES - Italia 3
FR - Francia 3
MA - Marocco 3
CZ - Repubblica Ceca 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BB - Barbados 1
KE - Kenya 1
LB - Libano 1
NL - Olanda 1
PK - Pakistan 1
PT - Portogallo 1
Totale 1.087
Città #
Ashburn 80
Chandler 70
Jacksonville 42
Singapore 36
Fairfield 34
New York 26
Abidjan 23
Boardman 23
Dublin 23
Dallas 21
Beijing 19
Seattle 19
Centro 18
Houston 17
Hong Kong 15
Wilmington 15
Des Moines 14
Munich 13
Los Angeles 11
Cambridge 10
Porto 10
Lawrence 9
Princeton 9
Turku 9
Woodbridge 9
San Mateo 8
São Paulo 7
Chicago 6
Hefei 6
Ho Chi Minh City 6
Turin 6
Chiaravalle 5
Guangzhou 5
San Diego 5
Washington 5
Ann Arbor 4
London 4
Mexico City 4
The Dalles 4
Tokyo 4
Warsaw 4
Brooklyn 3
Columbus 3
Montreal 3
Moscow 3
Orem 3
Poplar 3
Ancona 2
Ankara 2
Boston 2
Chennai 2
Denver 2
Frankfurt am Main 2
Helsinki 2
Johannesburg 2
Manchester 2
Mumbai 2
Olomouc 2
Rome 2
San Francisco 2
Santa Clara 2
Secaucus 2
Segrate 2
Seoul 2
Arqua Petrarca 1
Augusta 1
Açailândia 1
Baoding 1
Birmingham 1
Brasília 1
Bridgetown 1
Buffalo 1
Catalão 1
Cedro 1
Cerquilho 1
Chiswick 1
City of London 1
Concord 1
Fayetteville 1
Francisco Beltrão 1
Gramado 1
Guarulhos 1
Hanoi 1
Helena 1
Hải Dương 1
Jequié 1
Kilburn 1
Lahore 1
Lisbon 1
Manaus 1
Marche 1
Maringá 1
Middleton 1
Nairobi 1
New Delhi 1
Ninh Bình 1
Norwalk 1
Olinda 1
Olot 1
Phoenix 1
Totale 746
Nome #
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 161
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 144
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 143
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 130
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 126
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 116
Hedgehog (Hh) Signaling is a Predictor of Clinical Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC). 108
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 106
Treatment of advanced small cell lung cancer 81
Totale 1.115
Categoria #
all - tutte 4.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.979


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202181 0 0 0 0 0 7 11 9 14 20 16 4
2021/202261 6 12 0 2 0 6 1 3 5 8 5 13
2022/2023178 11 28 12 15 12 33 0 4 39 1 18 5
2023/2024110 13 3 7 11 16 35 1 6 3 2 1 12
2024/2025176 33 15 3 2 13 5 6 3 32 11 27 26
2025/2026265 44 40 28 84 57 12 0 0 0 0 0 0
Totale 1.115